Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
2013558 citationsFerda Cevikbas, Xidao Wang et al.Journal of Allergy and Clinical Immunologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of M Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Feld more than expected).
This network shows the impact of papers produced by M Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Feld. The network helps show where M Feld may publish in the future.
Co-authorship network of co-authors of M Feld
This figure shows the co-authorship network connecting the top 25 collaborators of M Feld.
A scholar is included among the top collaborators of M Feld based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M Feld. M Feld is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Feld, M, et al.. (2020). The new PubMed – underestimated regulatory obstacles. Medical Writing. 29. 52–59.2 indexed citations
Feld, M, et al.. (1970). Atrial myxoma manifested as cerebral vascular disease.. PubMed. 112(3). 20–5.1 indexed citations
15.
Feld, M, et al.. (1958). Test chimique direct de la dominance hémisphérique; à propos d'une hémisphérectomie gauche.. Revue Neurologique. 99(5).1 indexed citations
16.
Hilleman, M. R., et al.. (1957). Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation.. PubMed. 16(2). 277–89.23 indexed citations
17.
Feld, M, et al.. (1955). [Left parieto-occipital autochthomus hydatid cyst disclosed during lymphocytic meningitis with relapse; surgical excision and recovery].. PubMed. 92(4). 297–300.4 indexed citations
18.
Feld, M, et al.. (1954). [Neurological and mental sequelae of tuberculous meningitis in children].. PubMed. 90(6). 712–70.
19.
Feld, M, et al.. (1953). [Epilepsy and pseudo-schizophrenic chronic syndrome due to congenital stenosis of the acqueduct; cure by ventriculostomy].. PubMed. 111(2 2). 242–9.1 indexed citations
20.
Lebovici, Serge, et al.. (1953). [Suprasellar calcifications associated with neuropsychiatric and endocrine sequelae of tuberculous meningitis treated with streptomycin].. PubMed. 10(6). 650–3.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.